Margaret E. Macy, Arlene Naranjo, Fan F. Zhang, Michael Acord, Thomas Cash, Steven G. DuBois, Jennie Haunani Foster, Kristin R. Knight, Michael D. Hogarty, Rajen Mody, Daniel A. Morgenstern, Marguerite T. Parisi, Navin Pinto, C. Patrick Reynolds, Michelle E Keyel, Barry L. Shulkin, David Simon Ziegler, Rochelle Bagatell, Julie R. Park, Kelly C. Goldsmith. "A phase 2 randomized study of chemoimmunotherapy with or without eflornithine (DFMO) in relapsed/refractory neuroblastoma: A Children’s Oncology Group (COG) report.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.10001